United States: It's Time To Change How Antibodies Are Claimed In Patent Strategy - Oblon, McClelland, Maier & Neustadt, L.L.P
The US Supreme Court announced its ruling May 18 in favor of Sanofi in its dispute with Amgen over the enablement requirement as it pertained to antibody claims.
Full Article